Angiographic evidence of proliferative retinopathy predicts neuropsychiatric morbidity in diabetic patients
Diabetic retinopathy (DR) is a common vasculopathy categorized as either non-proliferative (NPDR) or proliferative (PDR),characterized by dysfunctional blood-retinal barrier (BRB) and diagnosed using fluorescein angiography (FA). Since the BRB is similar in structure and function to the blood-brain barrier (BBB) and BBB dysfunction plays a key role in the pathogenesis of brain disorders, we hypothesized that PDR, the severe form of DR, is likely to mirror BBB damage and to predict a worse neuropsychiatric outcome. A retrospective cohort study was conducted among subjects with diabetes (N=2982) with FA-confirmed NPDR (N=2606) or PDR (N=376). Incidence and probability to develop brain pathologies and mortality were investigated in a 10-year follow-up study. We used Kaplan-Meier, Cox and logistic regression analyses to examine association between DR severity and neuropsychiatric morbidity adjusting for confounders. Patients with PDR had significantly higher rates of all-cause brain pathologies (P<0.001), specifically stroke (P=0.005), epilepsy (P=0.006) and psychosis (P=0.024), and a shorter time to develop any neuropsychiatric event (P<0.001) or death (P=0.014) compared to NPDR. Cox adjusted hazard ratio for developing all-cause brain impairments was higher for PDR (HR=1.37, 95% CI 1.16-1.61, P<0.001) which was an independent predictor for all-cause brain impairments (OR 1.30, 95% CI 1.04-1.64, P=0.022), epilepsy (OR 2.16, 95% CI 1.05-4.41, P=0.035) and mortality (HR=1.35, 95% CI 1.06-1.70, P=0.014). This is the first study to confirm that angiography-proven microvasculopathy identifies patients at high risk for neuropsychiatric morbidity and mortality..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
---|---|
Enthalten in: |
Psychoneuroendocrinology - 67(2016), Seite 163-170 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Serlin, Yonatan [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
doi: |
10.1016/j.psyneuen.2016.02.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1974580261 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1974580261 | ||
003 | DE-627 | ||
005 | 20230714190235.0 | ||
007 | tu | ||
008 | 160609s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.psyneuen.2016.02.009 |2 doi | |
028 | 5 | 2 | |a PQ20160719 |
035 | |a (DE-627)OLC1974580261 | ||
035 | |a (DE-599)GBVOLC1974580261 | ||
035 | |a (PRQ)c1814-3880e7bb3a25347b3f6e5970a0aad4f4df5fdd49bc9bfebf16ddaf592fcb25160 | ||
035 | |a (KEY)0011236420160000067000000163angiographicevidenceofproliferativeretinopathypred | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a 77.00 |2 bkl | ||
100 | 1 | |a Serlin, Yonatan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Angiographic evidence of proliferative retinopathy predicts neuropsychiatric morbidity in diabetic patients |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Diabetic retinopathy (DR) is a common vasculopathy categorized as either non-proliferative (NPDR) or proliferative (PDR),characterized by dysfunctional blood-retinal barrier (BRB) and diagnosed using fluorescein angiography (FA). Since the BRB is similar in structure and function to the blood-brain barrier (BBB) and BBB dysfunction plays a key role in the pathogenesis of brain disorders, we hypothesized that PDR, the severe form of DR, is likely to mirror BBB damage and to predict a worse neuropsychiatric outcome. A retrospective cohort study was conducted among subjects with diabetes (N=2982) with FA-confirmed NPDR (N=2606) or PDR (N=376). Incidence and probability to develop brain pathologies and mortality were investigated in a 10-year follow-up study. We used Kaplan-Meier, Cox and logistic regression analyses to examine association between DR severity and neuropsychiatric morbidity adjusting for confounders. Patients with PDR had significantly higher rates of all-cause brain pathologies (P<0.001), specifically stroke (P=0.005), epilepsy (P=0.006) and psychosis (P=0.024), and a shorter time to develop any neuropsychiatric event (P<0.001) or death (P=0.014) compared to NPDR. Cox adjusted hazard ratio for developing all-cause brain impairments was higher for PDR (HR=1.37, 95% CI 1.16-1.61, P<0.001) which was an independent predictor for all-cause brain impairments (OR 1.30, 95% CI 1.04-1.64, P=0.022), epilepsy (OR 2.16, 95% CI 1.05-4.41, P=0.035) and mortality (HR=1.35, 95% CI 1.06-1.70, P=0.014). This is the first study to confirm that angiography-proven microvasculopathy identifies patients at high risk for neuropsychiatric morbidity and mortality. | ||
540 | |a Nutzungsrecht: Copyright © 2016. Published by Elsevier Ltd. | ||
700 | 1 | |a Shafat, Tali |4 oth | |
700 | 1 | |a Levy, Jaime |4 oth | |
700 | 1 | |a Winter, Aaron |4 oth | |
700 | 1 | |a Shneck, Marina |4 oth | |
700 | 1 | |a Knyazer, Boris |4 oth | |
700 | 1 | |a Parmet, Yisrael |4 oth | |
700 | 1 | |a Shalev, Hadar |4 oth | |
700 | 1 | |a Ur, Ehud |4 oth | |
700 | 1 | |a Friedman, Alon |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Psychoneuroendocrinology |d Oxford [u.a.] : Elsevier, 1975 |g 67(2016), Seite 163-170 |w (DE-627)166469300 |w (DE-600)197636-9 |w (DE-576)014816296 |x 0306-4530 |7 nnns |
773 | 1 | 8 | |g volume:67 |g year:2016 |g pages:163-170 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.psyneuen.2016.02.009 |3 Volltext |
856 | 4 | 2 | |u http://www.sciencedirect.com/science/article/pii/S0306453016300397 |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26907995 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PSY | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_2120 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 77.00 |q AVZ |
951 | |a AR | ||
952 | |d 67 |j 2016 |h 163-170 |